Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), saw an insider alter his positioning with the company through an acquisition that began yesterday and was officially filed today, August 20th. Director Michael A. Zasloff purchased 3,500 shares of common stock at an average price of $9.99 per share. Moreover, Following this transaction, Zasloff has 17,639 shares directly invested in the company. As well, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) is a 443.37 million market cap company that is a specialty and generic pharmaceutical company.
The Company focuses primarily on developing, manufacturing, marketing and selling technically challenging generic and injectable and inhalation products. In addition, the Company’s generic product candidates at various development stages that leverage its various technical capabilities, including injectable technologies, including various delivery methods and sizes of pre-filled syringes, vials in solution, suspension and lyophilized forms.
Finally, there are no major hedge funds that are involved with the company at this current time.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.